Evidence map›Paper›PMID 40034249›Full record

ArticleJVS-vascular science2025

Atherosclerotic plaque instability in symptomatic non-significant carotid stenoses.

Paul Cyréus, Katarina Wadén, Sofie Hellberg, Otto Bergman, Mariette Lengquist, Eva Karlöf, Andrew Buckler, Ljubica Matic, Joy Roy, David Marlevi and 2 more

Abstract read
In one paragraph

Article in JVS-vascular science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paul CyréusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Katarina WadénDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Sofie HellbergDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Otto BergmanDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Mariette LengquistDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Eva KarlöfDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Andrew BucklerDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ljubica MaticDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Joy RoyDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
David MarleviDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Melody ChemalyDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ulf HedinDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Carotid endarterectomy for symptomatic carotid stenosis is recommended for patients with >70% stenosis, but not in those with <50%. Because non-significant, low-degree stenoses may still cause strokes, refined risk stratification is necessary, which could be improved by assessing biological features of plaque instability. To challenge risk-stratification based on luminal narrowing, we compared biological features of carotid plaques from symptomatic patients with low-degree (<50%) vs high-degree (>70%) stenosis and explored potential mechanisms behind plaque instability in low-degree stenoses. Methods: Endarterectomy specimens were taken from symptomatic patients with high-degree (n = 204) and low-degree (n = 34) stenosis, all part of the Biobank of Karolinska Endarterectomies. Patient demographics, image-derived plaque morphology, and gene expression analyses of extracted lesions were used for comparisons. Plaque biology was assessed by transcriptomics using dimensionality reduction, differential gene expression, and gene-set enrichment analyses. Immunohistochemistry was used to study proteins corresponding to upregulated genes. Results: The demographics of the two groups were statistically similar. Calcification, lipid-rich necrotic core, intraplaque hemorrhage, plaque burden, and fibrous cap thickness were similar in both groups, whereas the sum of lipid-rich necrotic core and intraplaque hemorrhage was higher ( Conclusions: Plaques from symptomatic patients with non-significant low-degree carotid stenoses showed morphologic and biological features of atherosclerotic plaque instability that were comparable to plaques from patients with high-degree stenoses, emphasizing the need for improved stroke risk stratification for intervention in all patients with symptomatic carotid stenosis irrespective of luminal narrowing. An increased expression of hypoxia-inducible factor 3A in low-degree stenotic lesions suggested mechanisms of plaque instability associated with tissue hypoxia and plaque angiogenesis, but the exact role of hypoxia-inducible factor 3A in this process remains to be determined. Clinical relevance: Carotid plaques from symptomatic patients with <50% stenosis show morphologic and biological features of plaque instability, comparable to high-degree stenosis, which emphasizes the need for improved stroke risk stratification beyond stenosis severity.

Indexed as

Atherosclerotic plaque instabilityDegree of stenosisHypoxiaStroke riskSymptomatic carotid stenosis

Identifiers

PMID40034249
PMCPMC11874528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.